What's in HALEON's pipeline?

HALEON has 37 drugs in our index: 5 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 30 in Phase 1.

Which companies overlap with HALEON's portfolio?

Top competitors by shared drug class: American University of Beirut Medical Center, Amneal Pharmaceuticals, LLC, Amorphical Ltd., Antibe Therapeutics Inc., Apsen Farmaceutica S.A..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/haleon.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

HALEON — Portfolio Competitive Intelligence Brief

HALEON pipeline: 5 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 2 Phase 3 0 Phase 2 30 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Sensodyne Sensitivity & Gum	Sensodyne Sensitivity & Gum	marketed	Desensitizing toothpaste with antimicrobial and anti-inflammatory agents	Sensory nerve fibers (potassium nitrate); bacterial cell membranes and gum tissue (stannous compounds)	Dental/Oral Care
Otrivine Congestion Relief	Otrivine Congestion Relief	marketed
SPF Standard Sunscreen	SPF Standard Sunscreen	marketed	Sunscreen / Photoprotective agent		Dermatology / Preventive Care
Parodontax Complete Protection	Parodontax Complete Protection	marketed			Dental/Oral Health
Sensodyne Rapid Relief	Sensodyne Rapid Relief	marketed
ENO Lime	ENO Lime	phase 3	Antacid		Gastroenterology
Vehicle Dentifrice	Vehicle Dentifrice	phase 3			Dental

Therapeutic area mix

Pain Management · 2
Dental · 1
Dental/Oral Care · 1
Dental/Oral Health · 1
Dermatology / Preventive Care · 1
Gastroenterology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

American University of Beirut Medical Center · 1 shared drug class
Amneal Pharmaceuticals, LLC · 1 shared drug class
Amorphical Ltd. · 1 shared drug class
Antibe Therapeutics Inc. · 1 shared drug class
Apsen Farmaceutica S.A. · 1 shared drug class
AstraZeneca · 1 shared drug class
Behar, Caren, M.D. · 1 shared drug class
Allergan · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for HALEON:

Cite this brief

Drug Landscape (2026). HALEON — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/haleon. Accessed 2026-05-13.